Mary J. Abuzzahab, MD

Children's Minnesota
St. Paul, Minnesota, United States

Disclosure information not submitted.

Presentation(s):

• SUN-201 - Safety and Effectiveness of Lonapegsomatropin in the Skybright Registry: Analysis of the First 100 Patients Enrolled with 2 Years of Follow-Up

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-689 - Efficacy and Safety of Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal in Prader-Willi Syndrome (PWS) (Study C614)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-723 - Weight Category Improvement Following Setmelanotide in Patients with Acquired Hypothalamic Obesity

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF44-05 - Long-Term Efficacy with Setmelanotide in Patients with Acquired Hypothalamic Obesity

  Monday, June 15, 2026
  10:00 AM - 10:15 AM CT